About Repairon
Repairon GmbH is a German biotech company based in Göttingen that focuses on the development of regenerative cell therapy for cardiac medicine. The company was founded in 2014 based on the research work of Prof. Dr. Wolfram-Hubertus Zimmermann and team from UMG, who have developed several tissue engineering technologies with proven applicability for organ repair and drug development. Repairon's lead therapeutic candidate, the artificial heart muscle tissue ("heart patch"), is currently being evaluated in the Phase 2 BioVAT-HF clinical trial as a biological ventricular support tissue in end-stage heart failure. The company is cooperating closely with the UMG and the DZHK.
Note: This article has been translated using a computer system without human intervention. LUMITOS offers these automatic translations to present a wider range of company presentation. Since this article has been translated with automatic translation, it is possible that it contains errors in vocabulary, syntax or grammar. The original article in German can be found here.
Advertisement
